GENB (Generate Biomedicines) Payments of Debt: $-8.16 Mil (TTM As of Dec. 2025)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines Payments of Debt?

Generate Biomedicines GENB +2.18% 6 Payments of Debt is $-8.16 Mil as of Dec. 2025. GuruFocus rates GENB with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Generate Biomedicines's Payments of Debt for the six months ended in Dec. 2025 was $-8.16 Mil.

Generate Biomedicines's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was $-8.16 Mil.

Generate Biomedicines Payments of Debt Related Terms

Generate Biomedicines Payments of Debt Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines Payments of Debt Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
Payments of Debt
-11.12 -8.16

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
Payments of Debt -11.12 -8.16
GENB
6GF Score
Generate Biomedicines Inc GENB
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was $-8.16 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-8.16 Mil mean?
Generate Biomedicines (GENB) has a Payments of Debt of $-8.16 Mil as of Dec. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Generate Biomedicines and its competitors.
Is Generate Biomedicines' Payments of Debt too high?
Generate Biomedicines' current Payments of Debt is $-8.16 Mil. Overall, Generate Biomedicines has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Generate Biomedicines' Payments of Debt compare to PVLA and SLBT?
Generate Biomedicines' Payments of Debt of $-8.16 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Biotechnology company?
A good Payments of Debt depends on the Biotechnology industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Generate Biomedicines and its competitors. Generate Biomedicines's current Payments of Debt is $-8.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Generate Biomedicines stock overvalued right now?
Generate Biomedicines (GENB) has a current Payments of Debt of $-8.16 Mil. The current Payments of Debt is $-8.16 Mil. Generate Biomedicines' overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Generate Biomedicines (GENB), the current Payments of Debt is $-8.16 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price